Old Web
English
Sign In
Acemap
>
Paper
>
Concomitant JAK2 V617F + ET and BCR-ABL + cML masked by Glivec therapy for GIST
Concomitant JAK2 V617F + ET and BCR-ABL + cML masked by Glivec therapy for GIST
2012
E Del Biondo
H De Raeve
G. Huysmans
K Hendrickx
E Wouters
Peter Vandenberghe
Peter Meeus
Keywords:
JAK2 V617F
GiST
ABL
Cancer research
breakpoint cluster region
Concomitant
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]